Filing Details
- Accession Number:
- 0001127602-22-021926
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-01 18:37:57
- Reporting Period:
- 2022-09-01
- Accepted Time:
- 2022-09-01 18:37:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1061983 | Cytokinetics Inc | CYTK | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1013419 | J Santo Costa | 350 Oyster Point Blvd South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-09-01 | 5,000 | $9.45 | 15,000 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-09-01 | 10,000 | $10.68 | 25,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-09-01 | 15,000 | $52.79 | 10,000 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2022-09-01 | 5,000 | $0.00 | 5,000 | $9.45 |
| Common Stock | Non-Qualified Stock Option (Right to Buy) | Disposition | 2022-09-01 | 10,000 | $0.00 | 10,000 | $10.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-05-16 | 2028-05-16 | No | 4 | M | Direct |
| 0 | 2020-05-15 | 2029-05-15 | No | 4 | M | Direct |
Footnotes
- Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on July 1, 2022.
Billionaire Hedge Funds
